A study by Zhao et al. (23) demonstrated that elevated levels of IGF-1 were associated with increased bladder cancer risk, while higher levels of IGF-binding protein-3 were protective, with a dose–response relationship between these factors and cancer risk. Here, IGFBP3 is linked to urinary bladder cancer.